The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q4 2022 call → NO我们根据指令,需要判断管理层是否在电话会议中传达:报告期结果不代表公司当前实际运营的业务,即报告期数字已经过时,公司现在已领先于报告期所显示的水平。关键是要看管理层是否反复或实质性地指出这种差距,并基于已经实际发生的事物(如当前活动、已完成工作、已承诺的业务或已具备的能力),而非仅基于未来计划或希望。 分析电话会议内容: - 管理层在开场白中强调2022年第四季度业绩强劲,并提到多项进展,如提交aflibercept 8mg的BLA、Libtayo获批等。这些是常规的季度更新。 - 关于Eylea,管理层提到市场份额恢复,但未暗示报告期数字过时。 - 关于Dupixent,提到增长和新增适应症,但这是正常进展。 - 关于肿瘤学,提到多个管线进展,但这些都是未来计划或正在进行的研究,并非已实现的结果。 - 关于COPD,提到即将公布数据,但这是未来事件。 - 关于成本协同平台,提到早期数据,但仍在开发中。 - 财务指引方面,给出了2023年预期,但这是常规指引。 管理层没有明确表示报告期数字已经过时,或者公司当前业务已显著超越报告期。他们谈论的是未来计划和正在进行的工作,但并未指出报告期数字与当前运营之间存在实质性差距。例如,他们没有说“报告期没有反映我们最近启动的X”或“我们现在已经处于不同水平”。相反,他们是在总结过去并展望未来。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.